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a  b  s  t  r  a  c  t
Although  c-Fos  protein  is  one  of  the  principal  molecules  in intracellular  signaling,  c-fos  gene  disruption  is
associated  with  alterations  in  neuronal  functions  that  do  not  correspond  to  its importance  in function.  The
aim of  the  study  was  to evaluate  the changes  of  dopaminergic  system  together  with  acetylcholinesterase
(AChE)  in  c-fos  disruption  (KO).  KO  male  mice  showed  an increase  in  D1-like receptor  (279%  of  WT)
and  D2-like receptor  (345%  of  WT)  binding  sites  in  the  cortex.  On  the gene  expression  level  (assessed
by  real-time  PCR),  lower  quantities  of D1R-mRNA  (0.64)  and  D5R-mRNA  (0.6)  were  found  in females
when  compared  to males  in  the frontal  cortex,  higher  D2R-mRNA  in  the  parietal  (1.43)  and  temporal
(2.64)  cortex  and  lower  AChE-mRNA  (0.67).  On  the contrary,  female  striatum  contained  higher  level  of
D2R-mRNA  (1.62)  and  AChE-mRNA  (1.57)  but lower  level  of  D3R-mRNA  (0.73).  Hypothalamic  D1R-mRNA,
D2R-mRNA  and  D4R-mRNA  were  higher  in  females  (1.38,  1.63,  and  1.68,  respectively).  Disruption  of c-fos
increased  selectively  D5R-mRNA  (1.31)  in male  parietal  cortex,  D2R-mRNA  (1.72)  in male  temporal  cortex,ippocampus and cerebellar  D2R-mRNA  in  both  males  (1.43)  and  females  (1.42), respectively.  In females,  we  found
rather  decrease  in DR-mRNA.  Multiple  correlations  in  mRNA  quantities  (in  WT  mice) were  found,  which
changed  considerably  upon  c-fos  KO. Main  interactions  in WT  were  inter-regional,  CNS  of  KO  underwent
an extensive  restructuring  comprising  intraregional  interactions  in the  frontal  cortex,  hypothalamus,  and
cerebellum.  These  changes  in  DR (between  others)  could  be considered  as  one  of the adaptive  mechanisms
in c-fos  KO  mice.. Introduction
C-Fos protein is a molecule that can be viewed from many
oints. From the signaling point of view, it is a third messenger
hat activates its target genes [25], it can be comprehended as an
nducible transcription factor [13] or as a product of immediate
arly genes [16]. It is important to note that all these aspects cannot
e clearly separated. Usually, c-fos is considered as an ubiquitous
olecule that can give the picture of the cell activation, especially
eurons [31]. In respect to G-protein coupled receptors, c-Fos is
ctivated by multiple pathways. For example, it can be activated
oth by proteinkinase C (that is caused by diacylglycerol increase
rom enhanced phospholipase C activity) and by Ca2+ increase (that
s caused by inositoltrisphosphate increase from enhanced phos-
holipase C activity) [4]. The expression of c-Fos can be enhanced
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by an activation of muscarinic receptors [6],  -adrenoceptors, -
adrenoceptors [42], D1-like dopamine receptors, D2-like dopamine
receptors and many others [32]. Similarly, D1 agonists are able to
change c-fos gene expression [20]. In conclusion, c-Fos can be con-
sidered as very important molecule in cell signaling participating
in many physiological processes [9,24].
In nineties of 20th century and at the beginning of 21st century,
the knock-out of the target gene was considered to be the superior
method for studying the functions of the target gene. On the other
hand, many knock-out (KO) animals that were first believed not to
be viable, as the deleted gene was  considered to be essential for
survival, were surprisingly able to live till the adulthood (AChE KO
mice [29], for example).
Similarly, despite important role of c-Fos in the CNS function (c-
fos is target of many signaling systems, activated by huge amount
of receptors, transcription factors and c-fos could be considered
as essential in neuronal function), c-fos KO animals are fully viable
with disruption of CNS functions that is not fully in accordance with
the principal role of c-Fos in the cell. These animals have changes
in the acquisition and/or consolidation, but do not have long-term
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uthors [40] compared acute fos inhibition (using microinfusion
f antisense oligodeoxynucleotide directed against c-fos mRNA)
nd permanent deletion of fos gen (c-fos KO) and concluded that
he genetic deficiency in c-fos −/− mice caused normal acquisition
nd retention and that some other factors could compensate condi-
ioned taste aversion mechanism when Fos mediated transcription
s not available.
In addition to that, KO mice do not reveal dramatic changes
n REM sleep, in the core temperature, although they have
ore weakfullness and less slow wave sleep, and the null mice
re awake more over a 24 h period than WT  mice [35]. Also,
ice lacking c-Fos specifically in the CNS showed normal gen-
ral and emotional behavior but were specifically impaired in
ippocampus-dependent spatial and associative learning tasks [8].
Moreover, c-fos KO mice do not reveal changes in basal neu-
otensin, neuromedin, preprotachykinin and preproenkephalin
evels in the striatum as well [34]. These peptides are tightly
onnected with dopamine receptor system. Similarly, dopamine
ystem is also connected with learning and memory processes [38]
s well as it is connected (together with c-Fos) with biorhythm
ormation [39]. Dopamine receptors are implicated in many neu-
ological processes, including motivation, pleasure, cognition,
emory, learning [30], and fine motor control, as well as modu-
ation of neuroendocrine signaling [11].
Taken together, since there is discrepancy between the impor-
ance of c-Fos in the signaling processes and CNS function
mpairment (i.e. no changes in emotional behavior, in REM sleep,
n the core temperature) that does not correspond to the c-Fos sig-
aling significance, we hypothesized that functional adaptation in
-fos KO mice should exist.
In order to evaluate a dopamine receptor signaling status and
ts role for maintaining non adequately impaired CNS function in
-fos KO mice, we have employed the mice with targeted disrup-
ion of c-fos gene [37] and evaluated dopamine receptor binding
nd dopamine receptor mRNA levels (dopamine receptor sub-
ype gene transcripts) in selected central nervous system regions
i.e. brain areas: frontal, parietal, temporal and occipital cortex,
ig. 1. The changes in receptor binding characteristics in cortex and cerebellum of c-fos K
ales  of c-fos KO mice, *p < 0.05, **p < 0.01; differences from wild type.lletin 87 (2012) 511– 520
cerebellum, and subcortical structures: hypothalamus, striatum
and hippocampus). Moreover, we strived to analyze pre-existing
correlations in dopamine receptor gene transcripts (in wild type
mice) and to compare these to the c-fos KO counterparts. Hence, we
have hypothesized that restructuring of dopamine receptor signal-
ing can help the brain neurons to maintain intracellular signaling
balanced. The change in intracellular gene-gene and signaling
molecules interactions could be the basis of relatively preserved
CNS functions in this genetic mutant.
2. Material and methods
2.1. Animals
The c-fos mutation was produced by gene targeting [21]. This line was then
transferred in the Institute for Molecular Pathology, University of Vienna, Austria
from which we obtained this line. The line was  maintained on mixed genetic
background derived from (C57BL/6Jx129/SvJ)F1 mice. Mice were kept at constant
temperature (21 ◦C ± 1) in 12-h light/12-h dark cycle (lights on at 6:00 AM)  with
food and water ad libitum. Wild-type (WT, +/+) and knock-out (KO, −/−) were
obtained directly by crossing heterozygotes (+/−), adult (2-months old) male and
female control (n = 16) and knock-out (n = 11) mice (20–25 g of body weight) were
used for the study. WT and KO genotype were confirmed by PCR as described pre-
viously [21]. Although the KO mice had lower weight, the viability of both lines was
comparable and there was  no difference in the brain morphology (as assessed by
light  microscopy). Mice were sacrificed by decapitation and exsanguination and spe-
cific parts of cerebral cortex, cerebellum, hypothalamus, striatum, and hippocampus
were dissected, flash frozen in liquid nitrogen and stored at −80 ◦C for the further
analysis. For binding experiments, the whole cerebellum and cortex was taken, for
Real-Time PCR the specific brain regions were isolated by punch method isolating
as  much tissue as possible. All experiments were carried out in accordance with
the National Institute of Health Guide for the Care and Use of Laboratory Animals
(NIH Publications No. 80-23) revised 1996, the UK Animals (Scientific Procedures)
Act  1986 and associated guidelines, the European Communities Council Directive of
24  November 1986 (86/609/EEC). The experiments were agreed by Committee for
Animal Care of the Institute of Experimental Endocrinology in Bratislava, Slovakia.
2.2. Binding experimentsBinding experiments were performed similarly as described previously [14].
Briefly, in preliminary experiments, the receptors were bound with increasing
concentrations of radioligand in order to ascertain the saturating concen-
tration of radioligand, and the affinity of receptor to radioligand (KD). The
O mice. See inserted legend for explanation. WT/M males of wild type mice, KO/M
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Fig. 2. The changes of gene expression in the frontal, parietal, temporal and occipital cortex, comparison of changes in males/females and between WT and KO animals.
WT/M  males of wild type mice, KO/M males of c-fos KO mice, WT/F females of wild type mice, KO/F females of c-fos KO mice. See legend below for explanation, *p < 0.05,
different  from appropriate WT, **p < 0.01, different from appropriate WT, #p < 0.05, different from another sex, ###p < 0.001, different from another sex. a.u., arbitrary units.
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3adioligands used were: H-SCH 23990 (specific for D1-like dopamine receptors),
nd 3H-spiperon (specific for D2-like dopamine receptors). Afterwards, simplified
aturation binding experiments with one saturating concentration of radioligand
ere used in order to determine the receptor density (Bmax). Following for-
ula was  used: Bmax = B × ([L] + KL)/[L], where B = bound of radioligand [fmol/mg
ig. 3. The changes of gene expression in subcortical structures (hippocampus, hypoth
etween WT and KO animals. WT/M males of wild type mice, KO/M males of c-fos KO mic
 for explanation, *p < 0.05, different from appropriate WT, **p < 0.01, different from appro
hanges of dopamine receptors and acetylcholinesterase gene expressions in respective 
hown.lletin 87 (2012) 511– 520of protein], L = radioligand concentration [fmol/l], and KL = Kd [fmol/l] of the radi-
oligand. Homogenates were incubated in duplicates in Tris-EDTA buffer (Tris–HCl
50  mmol/l, EDTA 2 mmol/l, pH adjusted to 7.4) with following single fully saturating
concentration of the radioligand: 4000 pmol/l of 3H-SCH23390 for D1-like dopamine
receptors and 4000 pmol/l of 3H-spiperon for D2-like dopamine receptors.
alamus, striatum) and cerebellum, comparison of changes in males/females and
e, WT/F females of wild type mice, KO/F females of c-fos KO mice. See legend in Fig.
priate WT, ###p < 0.001, different from another sex. a.u., arbitrary units. Significant
areas are shown only, when there was no difference, the appropriate figure is not
































































Fig. 4. Schematic representation of dopamine subtype receptor and AChE inter-
actions in cerebral cortex of WT mice (top) and KO mice (bottom). N, negativeJ. Benes et al. / Brain Resea
.3.  Real-time PCR
Total mRNA was  isolated using chloroform–isopropanol (RNA Bee) method
ccording to manufacturer’s instructions. RNA yield and integrity was evaluated
pectrophotometrically at A1 = 260 nm and A1/A2 = 260/280 nm,  respectively.
amples with A1/A2 between 1.6 and 1.9 were used for downstream procedures.
otal RNA was purified to eliminate potentially contaminating genomic DNA
sing recombinant DNAse. Purified mRNA was  subsequently transcribed into
DNA using Ready-To-Go You-Prime First-Strand Beads. qPCR was performed
sing pre-mixed SYBRGreen MasterMix in a final volume of 25 L on a CFX-96
eal-Time PCR apparatus (Bio-Rad). All reactions were performed in triplicates
ith a no-reverse transcription control. Each qPCR reaction was followed by
 subsequent melting-curve analysis to ensure specificity. The following pro-
ocol was used: 3 min  for initial denaturation at 95.0 ◦C followed by 40 cycles
onsisting of 1 min at 94.0 ◦C for denaturation, 30 s for annealing at tempera-
ures that were optimized before for each primer-pair and 30 s for elongation
t  72.0 ◦C. The annealing temperatures were: 53.3 ◦C for D1 receptors, 58.7 ◦C
or  D2 receptors, 60.5 ◦C for D3 receptors, 52.9 ◦C for D4 receptors, 61.5 ◦C for
5 receptors, 56 ◦C for AChE and 60.5 ◦C for GAPDH. The primers were the
ame as described in [27], [41] and [23]. In detail, the primer sequences were
s  follows: D1 (sense): 5′-GTAGCCATTATGATCGTCAC-3′ , D1 (antisense): 5′-
ATCACAGACAGTGTCTTCAG-3′ , D2 (sense): 5′-GGGATGTTGCAGTCACAGTG-3′ ,
2  (antisense): 5′-GAGGGCTCCACTAAAGGAGG-3′ , D3 (sense): 5′-
GGTTTCTGTCAGATGCC-3′ , D3 (antisense): 5′-GTTGCTGAGTTTTCGAACC-3′ ,
4 (sense): 5′-CACCAACTACTTCATCGTGA-3′ , D4 (antisense): 5′-
AGGAGCAGACGGACGAGTA-3′ , D5 (sense): 5′-CTACGAGCGCAAGATGACC-3′ ,
5 (antisense): 5′-CTCTGAGCATGCTCAGCTG-3′ , AChE (sense) 5′-
CAGCAATATGTGAGCCTGA-3′ , AChE (antisense) 5′-GGTCGAACTGGTTCTTCCAG-3′ ,
APDH (sense): 5′-CGTCTTCACCACCATGGAGA-3′ , GAPDH (antisense): 5′-
GGCCATCACGCCACAGCTT-3′ . In order to determine the relative gene expression,
he Delta–Delta-Ct (ddCt) method was used. The levels of analyzed transcripts
ere  normalized to the level of the reference gene transcript (glyceraldehyde-3-
hosphate dehydrogenase, GAPDH, which level was practically the same in WT
nd KO). As another control, we  have employed also different internal control
18SrRNA) with another dopamine receptor probe (TaqMan, Applied Biosystems)
nd the results were similar to those with GAPDH. Then, for each sample the
ollowing formula was used: normalized ratio = 2expCT1−CT2, where CT1 is CT
f  reference transcript and CT2 is CT of target transcript, where CT is the cycle
hreshold. After the qPCR reaction, melting curve analysis was  performed to
onfirm the specificity of the analyzed transcript. No-template controls (NTC) and
on-reverse transcription reactions (NRT) were performed as negative controls.
.4. Material
3H-SCH23390, [N-methyl-3H] (3.15 TBq/mmol), 3H-spiperon (8-[4-(p-
uorophenyl)-4-oxo[2,3(n)-butyl]-1-phenyl 1,3,8-triazospiro[4,5]decan-4-one)
benzene ring-3H] (0.56 TBq/mmol) were purchased from Perkin-Elmer (Boston,
A,  USA), RNA Bee was purchased from TelTest (TX, USA), DNAse was purchased
rom  Ambion (United Kingdom) pre-mixed SYBRGreen MasterMix was  purchased
rom Top-Bio (Czech Republic), and Ready-To-Go You-Prime First-Strand Beads
ere from GE Healthcare (Czech Republic). Other chemicals were purchased from
igma–Aldrich (Czech Republic).
.5. Data treatment and statistical analysis
Radioligand binding and dopamine receptor subtype gene expression (D1R-
RNA–D5R-mRNA) normalized to housekeeper gene (GAPDH) was evaluated
sing GraphPad software (San Diego, USA). Statistical significance was deter-
ined with one-way, two-way ANOVA with SNK (Student–Newman–Keuls) post
oc test or with Student t-test, when appropriate. Subsequently, the relative
mounts of each receptor subtype mRNA (D1R-mRNA–D5R-mRNA) were plotted
gainst each other. Correlations were analyzed by calculating Pearson’s correla-
ion coefficient (r), coefficient of determination (r2), with corresponding p-values




Receptor densities were determined in male cortex and cere-
ella. There was marked increase in D1-like receptor (279% of
T,  t-test, p = 0.0048) and D2-like receptor (345% of WT,  t-test,
 = 0.0375) binding in the cortex of c-fos KO males while no change
n receptor binding in cerebella (see Fig. 1).interaction, p, positive interaction, connecting lines: continuous line: positive inter-
action, dashed line: negative interaction, dotted line: both interactions. D1–D5
dopamine receptors, AChE, acetylcholinesterase.
3.2. The regions without gene expression of specific dopamine
receptor subtypes
In some brain regions, there was  no gene expression of certain
dopamine receptor subtypes found. These regions and subtypes are
as follows: no D3R-mRNA was found in the parietal cortex, occip-
ital cortex and temporal cortex. D4R-mRNA was not found in the
temporal cortex and no D1R-mRNA was  found in the cerebellum.
3.3. Comparison of gene expression in males and females (in wild
type animals)
In some brain regions and subcortical areas, there were differ-
ences in gene expression of specific dopamine receptor subtypes
in males and females. When compared males and females, females
had a lower level of D1R-mRNA (0.64) and D5R-mRNA (0.6) in the
frontal cortex (D1R-mRNA: 1-way ANOVA, p = 0.0095, F = 5.004,
degrees of freedom (df) = 23, D5R-mRNA: 1-way ANOVA, p = 0.0091,
F = 4.924, df = 25), higher level of D2R-mRNA (1.43) in the parietal
cortex (1-way ANOVA, p = 0.018, F = 4.146, df = 25) and higher
level of D2R-mRNA (2.64) and lower level of AChE-mRNA (0.67)
in the temporal cortex (D2R-mRNA: 1-way ANOVA, p = 0.002,
F = 6.833, df = 25, AChE-mRNA: 1-way ANOVA, p = 0.0098, F = 4.791,
df = 26) as well (Fig. 2). In the striatum (Fig. 3), D2R-mRNA and
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Fig. 5. Schematic representation of dopamine subtype receptor and AChE interactions in subcortical structures (hypothalamus and striatum) and with cerebral cortex of
WT  and KO mice. N, negative interaction, p, positive interaction, connecting lines: continuous line: positive interaction, dashed line: negative interaction, dotted line: both
interactions. D1–D5 dopamine receptors, AChE, acetylcholinesterase. FC, frontal cortex, PC, parietal cortex, OC, occipital cortex, TC, temporal cortex, CRBL cerebellum. The
interactions are schematized as comparison of interaction in WT (left side) and KO (right side) in hypothalamus, and striatum, respectively (from top to bottom). You can

























n  KO animals.
ChE-mRNA in females were significantly higher – 1.62 times and
.57 times, respectively mRNA (D2R-mRNA: 1-way ANOVA,
 = 0.0011, F = 7.556, df = 26, AChE-mRNA: 1-way ANOVA,
 = 0.0117, F = 4.588, df = 26) and D3R- was significantly lower
0.73, t-test, p = 0.0265). In the hypothalamus (Fig. 3) we have
ound a significantly higher level D1R-mRNA (1.38), D2R-mRNA
1.63) and D4R-mRNA (1.68) in females compared to males (D1R-
RNA: t-test, p = 0.0071, D2R-mRNAt-test, p = 0.0401, D4R-mRNA:
-test, p = 0.0087).
.4. Changes in gene expression in c-fos KO (comparison to wild
ype animals)
In mice, in which c-fos gene was disrupted, there were changes
n dopamine receptor subtypes gene expression and also in AChE
ene expression. In the frontal cortex (Fig. 2), we have found a
ecrease in D2R-mRNA (0.67, t-test, p = 0.0177) and AchE-mRNA
0.73, 1-way ANOVA, p = 0.0083, F = 5.042, df = 25) in females and
5R-mRNA in males (0.53, 1-way ANOVA, p = 0.0091, F = 4.924,
f = 25). In the parietal cortex (Fig. 2), there was  an increase in
5R-mRNA in males (1.31, t-test, p = 0.0416). In the occipital cortex
Fig. 2), there was a decrease in D4R-mRNA (0.44) in females (1-way
NOVA, p = 0.0079, F = 5.031, df = 26). In the temporal cortex (Fig. 2),
here was an increase in D2R-mRNA (1.72) in males (1-way ANOVA,
 = 0.002, F = 6.833, df = 25). In the cerebellum (Fig. 3), we found an
ncrease in D2R-mRNA (1-way ANOVA, p = 0.0341, F = 3.422, df = 26)in both males (1.43) and females (1.42). On the contrary, D1R-mRNA
was decreased (t-test, p = 0.0461) in males (0.75) in the striatum
(Fig. 3) and also in females (t-test, p = 0.0311) in the hippocam-
pus (0.7). In hippocampus (Fig. 3), we also found a decrease in
D5R-mRNA (t-test, p = 0.0409) in females (0.78).
3.5. Restructuring of dopamine receptor subtypes gene transcripts
Correlation analysis was  performed and only the interactions
(negative and positive) with p < 0.05 were considered as significant.
The interactions are then schematically driven in Figs. 4 and 5. Usu-
ally, the p was  less than 0.01. The example of interactions between
gene expressions is shown in Fig. 7.
As it is apparent from Figs. 4–6,  it is possible to describe main
interactions in wild type animals as interregional. This is mainly
true for cortico–cortical interactions (see Fig. 4 above), but also
for cortico–subcortical interactions (see Figs. 5 and 6, left). When
c-fos gene is disrupted the dopamine receptor gene transcripts
undergoes an extensive restructuring, which can be characterized
as favoring both intraregional interactions in cortical structures
(see Fig. 4, bottom) and intraregional interactions in subcorti-
cal structures (see Figs. 5 and 6, right). This dramatic increase in
intraregional interactions can be mainly seen in the hypothalamus
(see Fig. 5, top right), frontal cortex (see Fig. 4, bottom) and cere-
bellum (see Fig. 4, bottom). Moreover, the loss of inter-regional
interactions that is seen in KO animals (Figs. 5 and 6, right) is a




























ig. 6. Schematic representation of interactions among dopamine receptor subtyp
ith  cerebral cortex of WT and KO mice. For legend, see Fig. 5.
eature that can be observed in all subcortical structures (i.e. in cere-
ellum, hippocampus, striatum and hypothalamus). On the other
and, the decrease in intraregional interactions can be seen in the
emporal cortex of KO animals (see Fig. 4, bottom). In addition to
hat, frontocortical–cerebellar interactions that are almost missing
n WT  animals become suddenly present in KO mice (see Fig. 4).
Moreover, it can be observed in some regions that the reversal
f the correlation occurs. This is true for fronto–striatal interaction
etween frontocortical AChE and striatal D1 dopamine receptors,
hich is positive in WT  animals but becomes negative when no c-
os is present (Fig. 5). Similarly, parieto–striatal interaction (Fig. 5)
lso reverts when no c-fos is present. While parietocortical D1R-
RNA correlates positively with striatal D3R-mRNA in WT,  this
orrelation becomes negative in KO. Also, striato–occipitocortical
nteraction between striatal AChE-mRNA and occipitocortical D4R-
RNA also reveals reversal in the correlation type. From the
ositive correlation in WT  it becomes negative in KO (see Fig. 5).
he last reversal of correlation was found between temporocorti-
al AChE-mRNA and occipitocortical D4R-mRNA (Fig. 4). We  have
bserved a negative correlation between this pair of transcripts in
T  animals but positive in KO animals.
. Discussion
In our experiments, we have found that disruption of c-fos
ncreased selectively D5R-mRNA (1.31) in male parietal cortex,
2R-mRNA (1.72) in male temporal cortex, and cerebellar D2R-
RNA in both males (1.43) and females (1.42), respectively.
his increase is partially in accordance with changes in receptorNA and AChE mRNA in subcortical structures (hippocampus and cerebellum) and
densities determined in male whole cortex and cerebella (see
Fig. 1). There was marked increase in D1-like (i.e. D1R and/or D5R)
receptor (279% of WT)  and D2-like (D2R, and/or D3R, and/or D4R)
receptor (345% of WT)  binding in the cortex of c-fos KO males.
Although, we were not able to find more brain areas in which
the increase in mRNA level correspond to the increase in receptor
binding, there is clear connection between increased D5R-mRNA
in parietal cortex and increased D1-like receptors in the whole cor-
tex. Similarly, there is correlation between increased D2R-mRNA
in the temporal cortex and increased D2-like receptor binding.
As there is no selective ligand for D1–D5 receptor binding deter-
mination, measurement of mRNA levels could give us the better
picture of receptor changes than binding that should be consid-
ered as general pattern of changes. The number of binding sites
(in fact the number of receptors) is believed to be determined
by the level of protein translation, posttranslational modifications,
protein degradation processes and/or changes of their membrane
surface presentation [36]. Therefore, increased amount of mRNA
together with unchanged number of binding sites give evidence
about decreased level of protein translation and/or increased level
of protein degradation. The other possibility (change in membrane
surface presentation) seems to be less probable.
The detail analysis of the gene expression revealed that there
are region specific changes in the gene expression of dopamine
receptor subtypes that in some regions the gene expression differs
between males and females and that it is possible to find spe-
cific interactions in dopamine receptor subtype gene transcripts.
These interactions are mainly interregional in wild type animals
but extensively restructuralized in KO mice where the majority of
518 J. Benes et al. / Brain Research Bulletin 87 (2012) 511– 520

























triato–frontocortical interaction (top, right) and KO striato–striatal interaction (bo
nteraction is represented by intraregional interactions between
opamine receptor subtype gene transcripts and AChE gene tran-
cripts. Moreover, in four cases interregional interactions revert
s a result of c-fos knockout. From that point of view, the data
bout changes of receptor binding supports the idea of restruc-
uring of dopamine receptor subtypes in central nervous system
eurons as a tool for plasticity that plays its role in coping with
he deletion of the important gene (c-fos). More specifically, Fos
amily proteins (c-Fos, FosB, Fra-1, Fra-2) are part of the transcrip-
ion factor AP-1 [22]. G-protein coupled receptors are able to affect
os family proteins via proteinkinase C (both diacylglycerol and
a2+ increase) [4],  via activation of D1-like dopamine receptors and
2-like dopamine receptors [32]. Similarly, D1 agonists are able to
hange c-fos gene expression [20]. It is possible to hypothesize that
ack of the downstream signaling protein (c-Fos) affects the mRNAs
or D1–D5 dopamine receptors. Regional specificity of changed gene
xpression can give evidence about importance of these changes to
aintaining the neuronal function.
.1. Gender differences
Gender differences have been found to be important in
opaminergic function in striatum [2] on the level of receptor bind-
ng sites. Shortly, D1-like and D2-like receptor densities depend
n the presence of estrogens and gestagens: ovariectomy changes
hese numbers and also estrogen treatment down-regulates D2-likeright). R, correlation coefficient, R2, coefficient of determination.
dopamine receptor density. On the other hand, castration do not
change dopaminergic function [2].  It has been shown as well that
striatal densities of D1-like dopamine receptors are increased in
male rats [15] while D2-like dopamine receptors remain unchanged
[28].
The data describing gender differences in dopamine recep-
tor gene expression are sparse. Significantly higher D5 dopamine
receptor gene expression in female over male young have been
demonstrated in the striatum (in study of CB1-cannabinoid-
deficient mouse) despite of genotype [10] which was, however,
not found in our study (we  did not find any difference in D1 gene
expression between males and females). We  have also found stri-
atal D3 dopamine receptor gene expression to be lower in females
than in males. Gerald et al. have found no gender differences for D3
dopamine receptors. Also, no gender differences have been demon-
strated for D2 dopamine receptor in the striatum [19], which also
does not concur with our results. We  have found a higher (1.62
times) expression of D2 dopamine receptor subtype in females than
in males. It is possible that strain, age and/or species differences
may  play a role as it has been demonstrated for other physiolog-
ical/pathophysiological parameters (e.g. reactivity of airways [18]
and many others). In addition to changes in striatum, we  have iden-
tified other regions with different gene expression in males and
females. We  have found lower D1 and D5 dopamine receptor gene
expression in frontal cortex of females. In parietal and temporal cor-
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han in males. Hypothalamic gene expressions of D1, D2 and D4
opamine receptors were also higher in females.
Dopaminergic system gender differences are considered as pos-
ible mechanisms relevant to variation in drug abuse [17] as well
s in anxiety-like behavior [33]. Our data about differences in
opamine receptor subtype gene expression that are brain area
pecific could be one of the factors contributing to these differences.
rom that point of view it is interesting to note that the main differ-
nces between males and females were recorded in hypothalamus
nd striatum. The differences in the hypothalamus as a part of lim-
ic system could be relevant to such variances in female and male
rug abuse or anxiety-like behavior. In the striatum, we  have found
 higher level of D2R-mRNA and AChE-mRNA, while D3R-mRNA
as in females actually lower. Although one could hypothesize
hat motor skills differences can be found between genders, data
oth for mice [1] and for humans [26] do not confirm such differ-
nces.
.2. The effect of c-fos knockout
There are some data describing the plasticity of dopamine
eceptors under different conditions. For example, it has been
hown recently that dopamine receptors undergo plastic changes
n mesolimbic system as a result of drug-induced neuroadap-
ations in excitatory transmission in the ventral tegmental area
nd the nucleus accumbens [3].  Similarly, an exacerbation of
ethamphetamine-induced neurotoxicity in c-fos knockout mice
as shown [5,24].  Also, D1- and D2- dopamine receptor mesolimbic
nd mesostriatal plasticity was described after perinatal asfyxia in
ats [12]. On the other hand, according to our knowledge, this is the
rst report describing eight central nervous system areas undergo
 gene transcripts restructuring after the c-fos is knocked out (in
ice).
How the restructuring can maintain relatively preserved CNS
unctions is not clear but some previously published data could
xplain the adaptive role of dopamine restructuring in main-
aining CNS function in c-fos knockout mice. Fos family proteins
c-Fos, FosB, Fra-1, Fra-2) are part of the transcription factor
P-1 [22] and are involved in a large variety of biological pro-
esses. It has been shown previously [7] that a component of
P-1, Fra-1, can functionally substitute for the lack of c-Fos in
osl1 knock-in mice, suggesting that both Fra-1 and c-Fos would
xert their functions as adaptors for other transcription factors or
ven act as transcriptional repressors. In the light of these results,
he dopamine restructuring could result as adaptive mechanism
n CNS function that copes with changed transcription factors
ilieu.
We can therefore conclude that there exist interactions on
he level of dopamine receptor subtype gene transcripts between
ight specific central nervous system regions (i.e. brain areas:
rontal, parietal, temporal and occipital cortex, cerebellum, and
ubcortical structures: hypothalamus, striatum and hippocam-
us) in wild type mice and that these interactions are changed
hen c-fos gene is knocked out. While main interactions in wild
ype animals are interregional, in c-fos KO mice the central ner-
ous system undergoes an extensive restructuring resulting in
n establishment of both intraregional interactions in cortical
tructures (frontal cortex) and intraregional interactions in sub-
ortical structures (hypothalamus and cerebellum). On the other
and, the decrease in intraregional interactions can be seen in
emporal cortex. In addition to that, frontocortical–cerebellar inter-
ctions, that are almost missing in WT  animals reveal suddenly
n KO mice. Thus, the restructuring on the level of dopamine
eceptor subtypes gene transcripts may  play a role in help-
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